51
Participants
Start Date
May 31, 2006
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
Oral mucosal immunoprophylaxis (OMIP)
OMIP consists of a mixture of allergen extracts including 0.2 milliliters (mL) timothy grass, 0.2 mL cat, and 0.2 mL house dust mite for a total daily dose of 0.6 mL.
Placebo
The placebo consists of three 0.2 mL vials of solution mixed together for a total daily dose of 0.6 mL.
Royal Children's Hospital, Melbourne
Telethon Institute for Child Health Research, Perth
Mount Sinai School of Medicine, New York
Immune Tolerance Network (ITN)
NETWORK
National Institute of Allergy and Infectious Diseases (NIAID)
NIH